Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | See remarks | Aug 11, 2023 | Buy | $27.80 | 1,201,440 | 33,400,031 | 3,201,440 | Aug 15, 2023, 09:39 PM | |
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | See remarks | Aug 11, 2023 | Buy | $27.80 | 57,533 | 1,599,417 | 287,866 | Aug 15, 2023, 09:39 PM | |
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | See remarks | Aug 11, 2023 | Buy | $27.80 | 1,201,440 | 33,400,031 | 3,201,440 | Aug 15, 2023, 09:38 PM | |
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | See remarks | Aug 11, 2023 | Buy | $27.80 | 57,533 | 1,599,417 | 287,866 | Aug 15, 2023, 09:38 PM | |
PAND | Pandion Therapeutics, Inc. | Fuglesang Christopher | Director | Apr 01, 2021 | Option Exercise | $60.00 | 2,131,135 | 127,868,100 | 0 | Apr 01, 2021, 07:49 PM | |
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | 10% Owner | Mar 05, 2021 | Sale | $71.64 | 1,011,445 | 72,461,514 | 2,363,004 | Mar 09, 2021, 09:48 PM | |
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | 10% Owner | Oct 30, 2020 | Option Exercise | $101.00 | 800,006 | 80,801,060 | 1,765,562 | Oct 30, 2020, 09:54 PM | |
PAND | Pandion Therapeutics, Inc. | Fuglesang Christopher | Director | Jul 21, 2020 | Buy | $18.00 | 722,222 | 12,999,996 | 2,600,773 | Jul 21, 2020, 07:44 PM | |
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | 10% Owner | Oct 03, 2017 | Option Exercise | $7.86 | 267,966 | 2,106,213 | 1,227,774 | Oct 03, 2017, 06:21 PM | |
MRTX | Mirati Therapeutics, Inc. | Fuglesang Christopher | 10% Owner | Jan 06, 2017 | Buy | $5.60 | 286,163 | 1,602,513 | 1,037,994 | Jan 10, 2017, 05:00 PM |